Literature DB >> 10369584

Macular hole formation: new data provided by optical coherence tomography.

A Gaudric1, B Haouchine, P Massin, M Paques, P Blain, A Erginay.   

Abstract

OBJECTIVE: To establish the sequence of events leading from vitreofoveal traction to full-thickness macular hole formation.
METHODS: Both eyes of 76 patients with a full-thickness macular hole in at least 1 eye were examined by biomicroscopy and optical coherence tomography.
RESULTS: Sixty-one fellow eyes had a normal macula. Optical coherence tomograms showed central detachment of the posterior hyaloid over the posterior pole in 19 cases (31%) and a perifoveal hyaloid detachment not detected on biomicroscopy in 26 cases (42%). In the 4 impending macular holes, optical coherence tomography disclosed various degrees of intrafoveal split or cyst, with adherence of the posterior hyaloid to the foveal center and convex perifoveal detachment. In the 14 stage 2 holes, eccentric opening of the roof of the hole was observed, and in the 24 stage 3 holes, the posterior hyaloid was detached from the entire posterior pole.
CONCLUSIONS: In fellow eyes of eyes with macular holes posterior hyaloid detachment begins around the macula, but the hyaloid remains adherent to the foveolar center, indicating the action of anteroposterior forces. This results in an intraretinal split evolving into a cystic space, and then to the disruption of the outer retinal layer and the opening of the foveal floor, thus constituting a full-thickness macular hole.

Entities:  

Mesh:

Year:  1999        PMID: 10369584     DOI: 10.1001/archopht.117.6.744

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  87 in total

Review 1.  Idiopathic full thickness macular hole: natural history and pathogenesis.

Authors:  E Ezra
Journal:  Br J Ophthalmol       Date:  2001-01       Impact factor: 4.638

2.  B-scan ultrasonographic findings in the stages of idiopathic macular hole.

Authors:  M R Van Newkirk; M W Johnson; J R Hughes; K A Meyer; S F Byrne
Journal:  Trans Am Ophthalmol Soc       Date:  2000

3.  [Retinal ICG-accumulation after ILM-staining during macular hole surgery?].

Authors:  I Krömer; A Lommatzsch; D Pauleikhoff
Journal:  Ophthalmologe       Date:  2004-06       Impact factor: 1.059

Review 4.  [OCT in macular holes].

Authors:  A Hassenstein; F Scholz; G Richard
Journal:  Ophthalmologe       Date:  2004-08       Impact factor: 1.059

5.  Spontaneous outer retinal closure of stage 1B macular hole without vitreofoveal separation.

Authors:  Atsushi Takahashi; Taiji Nagaoka; Yuji Kato; Satoshi Ishiko; Akitoshi Yoshida
Journal:  Int Ophthalmol       Date:  2010-04-03       Impact factor: 2.031

6.  Enhanced vitreous imaging optical coherence tomography in primary macular holes.

Authors:  Atsushi Takahashi; Taiji Nagaoka; Akitoshi Yoshida
Journal:  Int Ophthalmol       Date:  2015-09-08       Impact factor: 2.031

7.  The design and validation of an optical coherence tomography-based classification system for focal vitreomacular traction.

Authors:  D H W Steel; L Downey; K Greiner; H Heimann; T L Jackson; Z Koshy; D A H Laidlaw; L Wickham; Y Yang
Journal:  Eye (Lond)       Date:  2016-01-15       Impact factor: 3.775

8.  MACULAR HOLE AFTER PARS PLANA VITRECTOMY FOR RHEGMATOGENOUS RETINAL DETACHMENT.

Authors:  Carlos A Medina; Angelica G Ortiz; Nidhi Relhan; William E Smiddy; Justin H Townsend; Harry W Flynn
Journal:  Retina       Date:  2017-06       Impact factor: 4.256

9.  High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography.

Authors:  Vivek J Srinivasan; Maciej Wojtkowski; Andre J Witkin; Jay S Duker; Tony H Ko; Mariana Carvalho; Joel S Schuman; Andrzej Kowalczyk; James G Fujimoto
Journal:  Ophthalmology       Date:  2006-11       Impact factor: 12.079

10.  Clinical findings in macular hole surgery with indocyanine green-assisted peeling of the internal limiting membrane.

Authors:  S Wolf; M B Reichel; P Wiedemann; U E K Schnurrbusch
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-05-08       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.